SECsense Logo

Krystal Biotech, Inc. 8-K Report: Key Updates from February 19, 2025

$KRYS
Form 8-K
Filed on: 2025-02-19
Source
Krystal Biotech, Inc. 8-K Report: Key Updates from February 19, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Identification:
  • Company Name: Krystal Biotech, Inc.
  • CIK Number: 0001711279
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-38210
  • EIN (Employer Identification Number): 82-1080209
  1. Document Type:
  • Filing Type: 8-K (Current Report)
  1. Filing Date:
  • Date of Report: February 19, 2025
  1. Contact Information:
  • Address: 2100 Wharton Street, Suite 701, Pittsburgh, PA 15203
  • Phone Number: 412-586-5830
  1. Period Covered:
  • Start Date: February 19, 2025
  • End Date: February 19, 2025
  1. XML and XBRL References:
  • The report is formatted in XBRL (eXtensible Business Reporting Language), which is used for electronic filing with the SEC.

Insights:

  • The 8-K filing indicates that Krystal Biotech, Inc. is reporting a significant event or update on the specified date. Such filings typically include information about corporate events, financial performance, or other significant changes impacting the company.
  • The use of XBRL suggests that the company is adhering to modern reporting standards, which enhances the accessibility and usability of financial data for investors and analysts.
  • The address indicates the company is based in Pittsburgh, Pennsylvania, which may be relevant for regional market analysis or understanding local economic conditions impacting the company.

Conclusion:

This section of the financial report provides essential details about Krystal Biotech, Inc.'s filing, including its identification, the nature of the report (8-K), and the timeline for the information reported. Further analysis would be needed to understand the content of the report itself for insights on the company's current events or performance.